Peter Wirth, Executive VP, Legal & Corporate Development at GENZYME CORP (GENZ), sold 48,216 shares at $50.51 ($2.4M) on 2010-05-17, disclosed to the SEC on 2010-05-19.
Scheduled sale ($2.4M) by Executive VP, Legal & Corporate Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RSTI | SELL | 2015-11-19 | $2.2M | — | Filing → |
| RSTI | BUY | 2013-02-12 | $342K | — | Filing → |
| RSTI | SELL | 2013-02-12 | $556K | — | Filing → |